Cognitive Tolerability with Once-Daily Trokendi XRVR (extended-release Topiramate) vs. Immediate-Release Topiramate

被引：0
|
作者：
O'Neal, W. [1 ]
Hur, E. [1 ]
Liranso, T. [1 ]
Brittain, S. [1 ]
Barr, P. [2 ]
Chung, H. [3 ]
Gu, T. [4 ]
Tunceli, O. [4 ]
Turner, R. [4 ]
机构：
[1] Supernus Pharmaceut Inc, Rockville, MD USA
[2] iTTM Indegene, Kennesaw, GA USA
[3] Healthcore Inc, Wilmington, DE USA
[4] HealthCore Inc, Wilmington, DE USA
来源：
HEADACHE | 2017年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS02
引用
收藏
页码：180 / 181
页数：2
相关论文
共 50 条
  • [1] Cognitive Tolerability with Once-Daily Trokendi XR® (extended-release topiramate) vs. Immediate-Release Topiramate
    O'Neal, Welton
    Hur, Elizabeth E.
    Liranso, Tesfaye
    Barr, Peri
    Chung, Haechung
    Gu, Tao
    Tunceli, Ozgur
    Turner, Ralph M.
    CEPHALALGIA, 2017, 37 : 87 - 88
  • [2] Cognitive tolerability and health outcomes with once-daily Trokendi XR® (extended-release topiramate) in migraineurs
    O'Neal, W.
    Hur, E.
    Liranso, T.
    Brittain, S.
    Barr, P.
    Chung, H.
    Gu, T.
    Tunceli, O.
    Turner, R.
    JOURNAL OF PAIN, 2017, 18 (04): : S67 - S67
  • [3] Steady-State Bioequivalence of Extended-Release Once-Daily Trokendi XR® to Immediate-Release Topiramate (TPM-IR, Topamax®)
    Roers, E.
    Brittain, S. T.
    Baroldi, P.
    HEADACHE, 2016, 56 : 37 - 38
  • [4] Retrospective Claims-Based Comparative Health Outcomes Study: Trokendi XR® (extended-release topiramate) vs. Immediate-Release Topiramate
    O'Neal, W.
    Hur, E. E.
    Liranso, T.
    Turner, R. M.
    HEADACHE, 2016, 56 : 43 - 43
  • [5] Retrospective Claims-Based Comparative Health Outcomes Study: Trokendi XR® (extended-release topiramate) vs. Immediate-Release Topiramate as Migraine Preventives
    O'Neal, Welton
    Hur, Elizabeth E.
    Liranso, Tesfaye
    Chung, Haechung
    Gu, Tao
    Tunceli, Ozgur
    Turner, Ralph M.
    CEPHALALGIA, 2017, 37 : 88 - 89
  • [6] Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation
    Bialer, Meir
    Shekh-Ahmad, Tawfeeq
    Braun, Tricia L.
    Halvorsen, Mark B.
    EPILEPSIA, 2013, 54 (08) : 1444 - 1452
  • [7] Real-world assessment of treatment with extended-release topiramate (Trokendi XR®) and comparison with previous immediate-release topiramate treatment
    O'Neal, Welton
    Hur, Elizabeth E.
    Liranso, Tesfaye
    Patel, Barry
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (11) : 1095 - 1105
  • [8] Development and Optimization of Once-Daily Extended-Release Formulations of Topiramate
    Lambrecht, Lawrence J.
    Todd, Wesley M.
    Halvorsen, Mark B.
    NEUROLOGY, 2011, 76 (09) : A50 - A50
  • [9] Pharmacokinetic Equivalence between Immediate-Release and Extended-Release Topiramate
    Lambrecht, Lawrence J.
    Todd, Wesley M.
    Halvorsen, Mark B.
    ANNALS OF NEUROLOGY, 2011, 70 : S32 - S33
  • [10] Topiramate Extended-Release (Trokendi XR) for Epilepsy
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1428): : 87 - 88
12345